Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics and Safety of Moxifloxacin (MFX468)

This study has been terminated.
(slow enrolment of patients and new insights)
Sponsor:
Information provided by (Responsible Party):
JWC Alffenaar, University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT01329250
First received: March 8, 2011
Last updated: November 17, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2016
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)